0 C
New York
Monday, March 2, 2026

Buy now

spot_img
Home Blog

Finally! UpToDate Joins the AI Party, But Is It Too Late?”

“In a move that’s been a long time coming, UpToDate, the medical profession’s trusted companion for decades, has finally hopped on the AI bandwagon. Last week, they announced a generative artificial intelligence update, and doctors across the globe responded with a collective, ‘About time!’

Over the past couple of years, doctors have been quick to embrace chatbot-like tools powered by large language models. These tools provide instant, well-researched answers to medical queries, promising to make physicians faster and smarter in their daily patient care decisions. Startups like OpenEvidence and Pathway, now acquired by Doximity, have already snagged hundreds of thousands of physician users.

So, it’s no surprise that clinicians have been wondering when UpToDate, the old guard that stood to lose the most to these shiny new AI tools, would catch up. After all, it’s the ‘obvious thing to do,’ as Jonathan Chen, a hospitalist and health care AI researcher at Stanford University, puts it. But the question remains: Is UpToDate’s AI update too little, too late?

Stay tuned to STAT+ to find out more!”

UnitedHealth’s Big AI Move: Duke’s Top Scientist Joins the Fold

UnitedHealth Group, the healthcare behemoth, has just snapped up a heavyweight in the AI world. Michael Pencina, Duke University’s top AI brain and chief data scientist at Duke Health, is now UnitedHealth’s new chief AI scientist. According to an internal memo seen by STAT, Pencina stepped into his new role this week, leaving behind his post at Duke.

At Duke, Pencina was on a mission to tighten the reins on AI tools in healthcare. He advocated for a national registry to track AI tools’ usage, development, and performance. He’s also a co-founder of the Coalition for Health AI, a group working to set standards for AI testing and oversight in healthcare.

With Pencina at the helm, UnitedHealth is set to supercharge its AI efforts across its vast network of businesses. Stay tuned for more on this story…

From ‘Hard’ Plants to Weight Loss Pills: How Telehealth Became Big Pharma’s Newest Sales Channel”

Picture this: you’re rushing through a subway station, or strolling down a bustling city street, when suddenly, you’re face-to-face with a cactus. Not just any cactus, but one with a distinct… bulge. Welcome to the world of telehealth marketing, where phallic plants and cheeky ads have become the norm. Around 2018, companies like Hims (now known as Hims & Hers) and Roman (now Ro) started plastering their ads on walls and subway cars, promising to make erectile dysfunction “easy.” “Erectile dysfunction meds prescribed online, delivered to your ‘friend’s’ door,” read one ad, offering a discreet, convenient solution. These weren’t your average healthcare ads – they were created by agencies behind direct-to-consumer brands like Warby Parker and Harry’s, giving them a hip, modern edge. Back then, virtual doctor visits were a novelty. Now, telehealth is a booming part of the U.S. healthcare system, and a goldmine for pharmaceutical marketing. Today, scroll through your social media feed or watch a streaming service, and you’ll likely see ads for erectile dysfunction drugs, weight loss pills, hair loss treatments, acne solutions, birth control, and more. From phallic plants to targeted online ads, telehealth has become big pharma’s newest sales channel.

Covid-19 Sparks Medical Gold Rush: Docs Snapping Up Licenses in All 50 States!”

Jonah Mink, a family medicine doctor, started collecting medical licenses like some people collect stamps – but with a twist. During the Covid-19 pandemic, Mink, who had completed his residency at the University of Pennsylvania in 2016, was already working for a digital health company. When physical clinics started closing, he and other docs saw the telehealth writing on the wall.

At the end of 2019, Mink had licenses in a mere four states. But by 2022, he had racked up 47 more, one for every state and the District of Columbia. Talk about a license to heal… and travel!

A decade ago, a multi-licensed doctor was a rare sight. Maybe they lived near a state border or were a specialist who wanted to see patients virtually. But since Covid-19 pushed patients online, the number of physicians seeking licenses in multiple states has skyrocketed to keep up with the booming telehealth industry.

Want to know more about this medical licensing frenzy? Keep reading…

AI-Driven Takeovers: Digital Health’s New Gold Rush!”

“Ever wondered what happens when a startup hits a growth wall? Just ask Tom Stanis, CEO of Story Health, a company helping heart failure patients and their providers. With big-name clients and expansion plans, but a 2022-funding hangover, Stanis faced a dilemma: beg for cash in a tight VC market or sell? Innovaccer, an AI powerhouse with $275M in fresh funding, made the choice easy. They snapped up Story Health in September, adding it to their list of four acquisitions in a year. CEO Abhinav Shashank has his eyes on becoming the go-to AI platform for health systems, and M&A is his fast track. But Story Health isn’t the only one cashing in. Big, well-funded digital health companies are on a shopping spree, snatching up smaller players left and right. Stay tuned for more on this digital health gold rush!”

Parkinson’s Care Revolution: Startups Land Millions, Team Up with Top Hospitals”

Tech startups are making waves in Parkinson’s disease care, scooping up millions in investments and forging key partnerships with renowned hospitals. Here’s what’s happening:

– Kneu Health, spun out of Oxford University, just raked in $5.6 million. Their smartphone app tracks movement, speech, and cognition, providing a comprehensive view of Parkinson’s symptoms over time. They’re already working with the NHS and big-name hospitals like Cedars-Sinai and Mass General Brigham. So far, they’ve raised a total of $11.2 million.

– Rune Labs, based in San Francisco, quietly raised another $11 million. Using an Apple Watch, their tech tracks Parkinson’s symptoms and they’re growing their partnership with Kaiser Permanente. With $57 million raised so far, they’re making a significant impact.

– Empatica just acquired PKG Health, another Parkinson’s tracking tech company that’s helped 35,000 people. Empatica’s tech is also used by pharma companies, making it a powerful player in the field.

Why the sudden surge in Parkinson’s tech? Well, the motor symptoms of this neurodegenerative disease, like tremors and changes in gait, are perfect for tracking with sensors in wearables and smartphones. Plus, doctors need better tools to monitor symptoms that vary from person to person and day to day. Right now, most evaluations are done in-person and rely on patients’ memories, which isn’t always reliable.

Stay tuned for more on this tech revolution in Parkinson’s care!

Democrat Senator Demands Transparency: ‘Show Me How You’re Using AI, Medicare Insurers!’

Sen. Richard Blumenthal (D-Conn.) is on a mission to get the nation’s top Medicare Advantage insurers to spill the beans on their AI usage. He’s sent letters to UnitedHealth Group, Humana, and CVS Health (which owns Aetna), asking them to dish the dirt on the AI tools they’re using to make decisions about patients’ care and coverage.

Blumenthal wants a full inventory of the AI products these companies are using, and he’s also keen to know what policies they’ve put in place to ensure these tools don’t overrule human clinicians. This comes after a Senate report found that these insurers’ use of AI and predictive tools has led to a significant increase in payment denials for care of seriously ill patients.

So, buckle up, insurers! Blumenthal, being the top Democrat on the subcommittee, is serious about getting to the bottom of this. Stay tuned for more updates…

“AI to the Rescue? Mass General Brigham’s Bold Move to Tackle Primary Care Doc Shortage Sparks Mixed Reactions

In a bid to tackle the critical shortage of primary care doctors, Mass General Brigham (MGB) has rolled out an innovative solution: an artificial intelligence-powered app called “Care Connect”. Launched on September 9, the platform is now available to the system’s 15,000 patients without a primary care physician.

Here’s how it works: the 24/7 chatbot interviews patients, reviews their medical records, and generates a list of potential diagnoses. It then arranges a telehealth appointment with a physician in as little as 30 minutes. MGB is one of the first healthcare systems in the country to introduce such an AI-driven solution.

However, not everyone is thrilled about this AI initiative. Several primary care doctors at MGB have expressed concerns. They argue that while AI is a useful tool, it’s not the main solution to the shortage. They believe that addressing the root cause—providing competitive pay and better working conditions—will attract and retain more primary care physicians in the state’s largest health system.

So, is AI the answer to the primary care doc shortage, or just a temporary fix? The debate continues as MGB’s AI app rolls out. Stay tuned for more updates!

Apple Watch’s Blood Pressure Feature: Why This Doc Is Pressing Pause”

Welcome to The Workup, your weekly dose of health tech insights from Vishal Khetpal. As a physician, I’ve seen firsthand how wearables like the Apple Watch have transformed patient check-ups. A quick peek at a patient’s wrist can reveal so much – heart rate trends, sleep patterns, or activity levels. So, when Apple unveiled its latest Series 11 and Ultra 3 watches with ‘hypertension notifications’, I was excited. This new feature tracks blood pressure trends over a month and alerts users to potential high blood pressure issues. But here’s why I’m being cautious about this shiny new feature.

Lyra’s Game-Changer: First Major Company to Launch ‘Therapy Bot’ Amid Mental Health & AI Frenzy”

Lyra Health made waves on Tuesday by unveiling its latest innovation: a chatbot designed to discuss mental health with its members, marking a significant milestone as the first major company to integrate generative AI into ongoing therapy treatment. This move places Lyra in the company of several smaller mental health startups that have been exploring the use of AI in their services.

While the tech world races ahead with AI-powered products in healthcare, concerns are mounting among experts, regulators, and lawmakers about the unpredictable nature of these tools. Recent incidents, such as users spiraling into delusions due to consumer bots like ChatGPT and alleged self-harm cases linked to AI, have raised red flags.

However, the popularity of consumer chatbots as makeshift therapists has inspired Lyra to develop its own offering. Jenny Gonsalves, Lyra’s chief product and technology officer, confirmed that the company began working on its chatbot, Lyra AI, last year in response to this trend.

Stay tuned to STAT+ for the full scoop on this groundbreaking development in mental health and AI.

Follow by Email
YouTube
WhatsApp